FDA's hormone therapy warning rollback sparks estrogen patch shortage
FDA's hormone therapy warning rollback sparks estrogen patch shortage The FDA's decision to rollback 'black box warnings' on hormone replacement therapy (HRT) in November 2025 has created an estrogen patch shortage. Dr. Janette Nesheiwat …